| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
4
4
3
5
1
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
D
(Sell)
|
#14 in Foreign Large Blend
U.S. News evaluated 213 Foreign Large Blend Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 20.95 percent over the past year, 8.97 percent over the past three years, and 0.06 percent over the past five years.
| Trailing Returns | Updated 04.30.2013 |
|---|---|
| Year to date | 10.2% |
| 1 Year | 21.0% |
| 3 Years (Annualized) | 9.0% |
| 5 Years (Annualized) | 0.1% |
| 10 Years (Annualized) | N/A |
Summary
The investment seeks total return greater than that of its benchmark, the MSCI EAFE Index. The fund is a fund of funds and invests primarily in shares of the International Equity Funds. It may invest in shares of other GMO funds, including the Fixed Income Funds, Alpha Only fund and Alternative Asset Opportunity Fund (the GMO funds in which the fund invests are collectively referred to herein as the "underlying funds") and may hold securities directly.
